Recruiting Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer NCT07227415 Conditions Adenocarcinoma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, +30 more Locations Mayo Clinic Building- Phoenix — Phoenix, Arizona, United States Mayo Clinic Arizona — Scottsdale, Arizona, United States Highlands Oncology Group — Fayetteville, Arkansas, United States Highlands Oncology Group — Rogers, Arkansas, United States View all 128 locations View more locations Show fewer locations Loading locations... View Trial Details
Completed A Study of Nivolumab Plus Ipilimumab in Participants With Renal Cell Cancer in the Real World Setting in Japan NCT04043975 Conditions Adenocarcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, +14 more Locations Local Institution - 0001 — Tokyo, Japan View Trial Details
Completed Study In Patients With Kidney Cancer Treated With Sutent NCT00873210 Conditions Adenocarcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, +15 more Locations Pfizer Investigational Site — Banská Bystrica, Slovakia Pfizer Investigational Site — Bojnice, Slovakia Pfizer Investigational Site — Bratislava, Slovakia Pfizer Investigational Site — Bratislava, Slovakia View all 14 locations View more locations Show fewer locations Loading locations... View Trial Details
Active, Not Recruiting Observational Real-life Study of Cabozantinib in Monotherapy or in Combination With Nivolumab in Advanced Renal Cell Carcinoma (RCC) NCT04106349 Conditions Adenocarcinoma, Advanced or Metastatic Renal Cell Carcinoma, Carcinoma, +14 more Locations Onze-Lieve-vrouw Ziekenhuis Aalst — Aalst, Belgium Imeldaziekenhuis — Bonheiden, Belgium Clinique Saint-Luc Bouge — Bouge, Belgium AZ Sint-Jan Brugge — Bruges, Belgium View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details
